Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Amdocs (DOX) over the last 17 years, with Q3 2025 value amounting to $8.5 million.

  • Amdocs' Change in Accured Expenses fell 9063.24% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.6 million, marking a year-over-year increase of 1322.29%. This contributed to the annual value of $1.2 billion for FY2025, which is 870.07% down from last year.
  • According to the latest figures from Q3 2025, Amdocs' Change in Accured Expenses is $8.5 million, which was down 9063.24% from $1.2 billion recorded in Q2 2025.
  • Amdocs' 5-year Change in Accured Expenses high stood at $1.2 billion for Q2 2024, and its period low was -$20.1 million during Q3 2022.
  • Over the past 5 years, Amdocs' median Change in Accured Expenses value was $990.3 million (recorded in 2022), while the average stood at $748.2 million.
  • In the last 5 years, Amdocs' Change in Accured Expenses plummeted by 27904.29% in 2022 and then soared by 118419.62% in 2024.
  • Quarter analysis of 5 years shows Amdocs' Change in Accured Expenses stood at $995.0 million in 2021, then rose by 3.87% to $1.0 billion in 2022, then plummeted by 90.73% to $95.8 million in 2023, then skyrocketed by 1184.2% to $1.2 billion in 2024, then tumbled by 99.31% to $8.5 million in 2025.
  • Its last three reported values are $8.5 million in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.